100 related articles for article (PubMed ID: 1381366)
1. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.
Høyer-Hansen G; Rønne E; Solberg H; Behrendt N; Ploug M; Lund LR; Ellis V; Danø K
J Biol Chem; 1992 Sep; 267(25):18224-9. PubMed ID: 1381366
[TBL] [Abstract][Full Text] [Related]
2. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.
Bernstein AM; Twining SS; Warejcka DJ; Tall E; Masur SK
Mol Biol Cell; 2007 Jul; 18(7):2716-27. PubMed ID: 17507651
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε.
Graziano F; Elia C; Laudanna C; Poli G; Alfano M
PLoS One; 2011; 6(8):e23674. PubMed ID: 21858203
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.
Alfano M; Sidenius N; Panzeri B; Blasi F; Poli G
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8862-7. PubMed ID: 12084931
[TBL] [Abstract][Full Text] [Related]
5. Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.
Isaksson GL; Hinrichs GR; Andersen H; Bach ML; Weyer K; Zachar R; Henriksen JE; Madsen K; Lund IK; Mollet G; Bistrup C; Birn H; Jensen BL; Palarasah Y
J Am Soc Nephrol; 2024 Apr; 35(4):410-425. PubMed ID: 38254266
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional interplay among the ligand-binding domains of the urokinase-plasminogen-activator-receptor-associated protein, Endo180.
Rivera-Calzada A; Robertson D; MacFadyen JR; Boskovic J; Isacke CM; Llorca O
EMBO Rep; 2003 Aug; 4(8):807-12. PubMed ID: 12856000
[TBL] [Abstract][Full Text] [Related]
7. Mycoplasma fermentans binds to and invades HeLa cells: involvement of plasminogen and urokinase.
Yavlovich A; Katzenell A; Tarshis M; Higazi AA; Rottem S
Infect Immun; 2004 Sep; 72(9):5004-11. PubMed ID: 15321992
[TBL] [Abstract][Full Text] [Related]
8. Ligand binding alters dimerization and sequestering of urokinase receptors in raft-mimicking lipid mixtures.
Ge Y; Siegel AP; Jordan R; Naumann CA
Biophys J; 2014 Nov; 107(9):2101-11. PubMed ID: 25418095
[TBL] [Abstract][Full Text] [Related]
9. Regulation of integrin function by the urokinase receptor.
Wei Y; Lukashev M; Simon DI; Bodary SC; Rosenberg S; Doyle MV; Chapman HA
Science; 1996 Sep; 273(5281):1551-5. PubMed ID: 8703217
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.
Alfano D; Franco P; Stoppelli MP
Front Cell Dev Biol; 2022; 10():818616. PubMed ID: 35493073
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.
Masucci MT; Minopoli M; Di Carluccio G; Motti ML; Carriero MV
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158766
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention.
Leth JM; Ploug M
Front Cell Dev Biol; 2021; 9():732015. PubMed ID: 34490277
[TBL] [Abstract][Full Text] [Related]
13. PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion.
Guo Q; Yaron JR; Wallen JW; Browder KF; Boyd R; Olson TL; Burgin M; Ulrich P; Aliskevich E; Schutz LN; Fromme P; Zhang L; Lucas AR
Front Cardiovasc Med; 2021; 8():633212. PubMed ID: 33665212
[TBL] [Abstract][Full Text] [Related]
14. Reduced Graphene Oxides Modulate the Expression of Cell Receptors and Voltage-Dependent Ion Channel Genes of Glioblastoma Multiforme.
Szczepaniak J; Jagiello J; Wierzbicki M; Nowak D; Sobczyk-Guzenda A; Sosnowska M; Jaworski S; Daniluk K; Szmidt M; Witkowska-Pilaszewicz O; Strojny-Cieslak B; Grodzik M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419226
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Study of the Diagnostic and Prognostic Utility of Soluble Urokinase-type Plasminogen Activator Receptor and Procalcitonin in Patients with Sepsis and Systemic Inflammation Response Syndrome.
Sharma A; Ray S; Mamidipalli R; Kakar A; Chugh P; Jain R; Ghalaut MS; Choudhury S
Indian J Crit Care Med; 2020 Apr; 24(4):245-251. PubMed ID: 32565634
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion.
Minopoli M; Botti G; Gigantino V; Ragone C; Sarno S; Motti ML; Scognamiglio G; Greggi S; Scaffa C; Roca MS; Stoppelli MP; Ciliberto G; Losito NS; Carriero MV
J Exp Clin Cancer Res; 2019 Nov; 38(1):459. PubMed ID: 31703596
[TBL] [Abstract][Full Text] [Related]
17. Multifaced Roles of the Urokinase System in the Regulation of Stem Cell Niches.
Dergilev KV; Stepanova VV; Beloglazova IB; Tsokolayev ZI; Parfenova EV
Acta Naturae; 2018; 10(4):19-32. PubMed ID: 30713759
[TBL] [Abstract][Full Text] [Related]
18. Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.
Ragone C; Minopoli M; Ingangi V; Botti G; Fratangelo F; Pessi A; Stoppelli MP; Ascierto PA; Ciliberto G; Motti ML; Carriero MV
J Exp Clin Cancer Res; 2017 Dec; 36(1):180. PubMed ID: 29216889
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells.
van Veen M; Matas-Rico E; van de Wetering K; Leyton-Puig D; Kedziora KM; De Lorenzi V; Stijf-Bultsma Y; van den Broek B; Jalink K; Sidenius N; Perrakis A; Moolenaar WH
Elife; 2017 Aug; 6():. PubMed ID: 28849762
[TBL] [Abstract][Full Text] [Related]
20. Physiology and pathophysiology of the plasminogen system in the kidney.
Svenningsen P; Hinrichs GR; Zachar R; Ydegaard R; Jensen BL
Pflugers Arch; 2017 Nov; 469(11):1415-1423. PubMed ID: 28656379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
